Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)

China flag China · Delayed Price · Currency is CNY
21.14
+0.81 (3.98%)
Nov 12, 2024, 3:00 PM CST
16.22%
Market Cap 70.25B
Revenue (ttm) 272.42B
Net Income (ttm) 4.03B
Shares Out 3.70B
EPS (ttm) 1.08
PE Ratio 19.57
Forward PE 15.56
Dividend 0.41 (2.02%)
Ex-Dividend Date Sep 24, 2024
Volume 65,042,083
Open 20.36
Previous Close 20.33
Day's Range 20.33 - 21.53
52-Week Range 15.36 - 23.20
Beta 0.30
Analysts n/a
Price Target n/a
Earnings Date Oct 28, 2024

About Shanghai Pharmaceuticals Holding

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, syste... [Read more]

Sector Healthcare
Founded 1994
Employees 48,164
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 601607
Full Company Profile

Financial Performance

In 2023, Shanghai Pharmaceuticals Holding's revenue was 260.30 billion, an increase of 12.21% compared to the previous year's 231.98 billion. Earnings were 3.77 billion, a decrease of -32.92%.

Financial Statements

News

There is no news available yet.